Tag: IBD-
Dipeptidyl Peptidase-4 Inhibitors in T2DM Linked to IBD
Higher risk of inflammatory bowel disease with longer use of dipeptidyl peptidase-4 inhibitor
Lymphoma Risk Up With Thiopurine, Anti-TNF Tx in IBD
Risk higher for those exposed to combination therapy versus thiopurine or anti-TNF monotherapy
Childhood-Onset IBD May Raise Risk of Cancer
Researchers think chronic inflammation in gastrointestinal tract may be driving force
Asthma Tied to Later Inflammatory Bowel Disease
Findings for Crohn's and early- or late-onset ulcerative colitis
Fecal Calprotectin Is Best Marker for Discriminating Pediatric IBD
Blood markers, fecal calprotectin aid discrimination between pediatric patients with, without IBD
Rates of Inflammatory Bowel Disease Down in Rural Areas
Rural living may have protective effect, Canadian study suggests
Genes Responsible for Crohn’s, Ulcerative Colitis Identified
Findings could improve efficacy of current treatments, lead to discovery of new drug targets
Five Factors Predict High Costs in Inflammatory Bowel Disease
Predictors include presence of psychiatric illness, use of corticosteroids and narcotics, low hemoglobin
Novel Diet Can Help Children With Crohn’s, Colitis Find Relief
Eating plan focuses on natural, non-processed foods, such as fruits, veggies, and nuts
Biologics Tied to Opportunistic Infection Risk in IBD
No increased risk of serious infection or malignancy among adults with inflammatory bowel disease
